High expression of hexokinase domain containing 1 is associated with poor prognosis and aggressive phenotype in hepatocarcinoma.

Abstract

Rapid progress and metastasis remain the major treatment failure modes of hepatocarcinoma (HCC). Unfortunately, the underlying molecular mechanisms of hepatoma cell proliferation and migration are poorly understood. Metabolic abnormalities play critical roles in tumorigenesis and progression. Hexokinase domain containing 1 (HKDC1) catalyzes the phosphorylation of glucose. However, the functions and mechanisms of HKDC1 in cancer remain unknown. In this study, real-time RT-PCR and Western blotting assays were used to detect the HKDC1 expression levels in HCC tissues and cell lines. The Oncomine™ Cancer Microarray Database was applied to analysis the correlations between HKDC1 expression and HCC clinical characteristics. MTT and Transwell migration assays were performed to determine the functions of HKDC1 in HCC cells. The effect of HKDC1 on Wnt/β-catenin signaling pathway was assessed using Western blotting assay. In this study, we found that HKDC1 expression levels were elevated in HCC tissues compared with the adjacent tissues. HCC patients with high expression levels of HKDC1 had poor overall survival (OS). Furthermore, higher HKDC1 levels also predicted a worse OS of patients within solitary, elevated pre-operated serum alpha fetoprotein (AFP) level and higher tumor diameter. Moreover, silencing HKDC1 suppressed HCC cells proliferation and migration in vitro. Downregulated HKDC1 expression repressed β-Catenin and c-Myc expression, which indicates that silencing HKDC1 may reduce proliferation and migration via inhibiting the Wnt/β-catenin signaling pathway in HCC. In summary, HKDC1 provides further insight into HCC tumor progression and may provide a novel prognostic biomarker and therapeutic target for HCC treatment.

• Authors: Zijian Zhang, Shanzhou Huang, Huanyu Wang, Jian Wu, Dong Chen, Baogang Peng, Qi Zhou
• Journal: Biochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 474 Issue 4 Pg. 673-679 (06 10 2016) ISSN: 1090-2104 [Electronic] United States
• PMID: 27155152 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2016 Elsevier Inc. All rights reserved.

Chemical References

• Biomarkers, Tumor
• HK1 protein, human
• Hexokinase

Topics

• Biomarkers, Tumor (metabolism)
• Carcinoma, Hepatocellular (enzymology, mortality, pathology)
• Cell Movement
• Cell Proliferation
• China (epidemiology)
• Hexokinase (metabolism)
• Humans
• Liver Neoplasms (enzymology, mortality, pathology)
• Neoplasm Invasiveness
• Prevalence
• Prognosis
• Risk Factors
• Survival Rate
• Up-Regulation